Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC

​ Conditions: Esophageal Squamous Cell Carcinoma (ESCC)

Interventions: Drug: Sugemalimab and Chemotherapy; Drug: Nab-paclitaxel; Drug: Cisplatin; Radiation: Radiation Therapy

Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Active, not recruiting Conditions: Esophageal Squamous Cell Carcinoma (ESCC)
Interventions: Drug: Sugemalimab and Chemotherapy; Drug: Nab-paclitaxel; Drug: Cisplatin; Radiation: Radiation Therapy
Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Active, not recruiting